{"id":"https://openalex.org/W2151820488","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1094","title":"Investigation of Two Dosing Schedules of Vandetanib (ZD6474), an Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, in Combination with Irinotecan in a Human Colon Cancer Xenograft Model","display_name":"Investigation of Two Dosing Schedules of Vandetanib (ZD6474), an Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, in Combination with Irinotecan in a Human Colon Cancer Xenograft Model","publication_year":2007,"publication_date":"2007-11-01","ids":{"openalex":"https://openalex.org/W2151820488","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1094","mag":"2151820488","pmid":"https://pubmed.ncbi.nlm.nih.gov/17975157"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-07-1094","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1094","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-1094","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020655022","display_name":"Teresa Troiani","orcid":"https://orcid.org/0000-0002-0646-4901","observed_orcids":["https://orcid.org/0000-0002-0646-4901"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["IT","US"],"is_corresponding":false,"raw_author_name":"Teresa Troiani","raw_affiliation_strings":["1Division of Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado; Departments of","4Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF Magrassi e A Lanzara,\u201d Seconda Universita\u0300 degli Studi di Napoli, Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado; Departments of","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"4Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF Magrassi e A Lanzara,\u201d Seconda Universita\u0300 degli Studi di Napoli, Napoli, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025904775","display_name":"Natalie Julie Serkova","orcid":"https://orcid.org/0000-0002-4573-3895","observed_orcids":["https://orcid.org/0000-0002-4573-3895"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natalie J. Serkova","raw_affiliation_strings":["2Anesthesiology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Anesthesiology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072152051","display_name":"Daniel L. Gustafson","orcid":"https://orcid.org/0000-0002-3063-1669","observed_orcids":["https://orcid.org/0000-0002-3063-1669"]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel L. Gustafson","raw_affiliation_strings":["3Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; and","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028506802","display_name":"Thomas K. Henthorn","orcid":"https://orcid.org/0000-0002-8993-3936","observed_orcids":["https://orcid.org/0000-0002-8993-3936"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas K. Henthorn","raw_affiliation_strings":["2Anesthesiology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Anesthesiology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054389969","display_name":"Owen Lockerbie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Owen Lockerbie","raw_affiliation_strings":["1Division of Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado; Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado; Departments of","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091914488","display_name":"Andrea L. Merz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Merz","raw_affiliation_strings":["3Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; and","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Long","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Long","raw_affiliation_strings":["3Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; and","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035039760","display_name":"Mark Morrow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Morrow","raw_affiliation_strings":["1Division of Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado; Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado; Departments of","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056034569","display_name":"Fortunato Ciardiello","orcid":"https://orcid.org/0000-0002-3369-4841","observed_orcids":["https://orcid.org/0000-0002-3369-4841"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fortunato Ciardiello","raw_affiliation_strings":["4Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF Magrassi e A Lanzara,\u201d Seconda Universita\u0300 degli Studi di Napoli, Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF Magrassi e A Lanzara,\u201d Seconda Universita\u0300 degli Studi di Napoli, Napoli, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048907012","display_name":"S. Gail Eckhardt","orcid":"https://orcid.org/0000-0002-8103-1620","observed_orcids":["https://orcid.org/0000-0002-8103-1620"]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Gail Eckhardt","raw_affiliation_strings":["1Division of Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado; Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado; Departments of","institution_ids":["https://openalex.org/I921990950"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0268,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.91658152,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"13","issue":"21","first_page":"6450","last_page":"6458"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9229000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9229000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.06340000033378601,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vandetanib","display_name":"vandetanib","score":1.0},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9760000109672546},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.8769999742507935},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.7889999747276306},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.6959999799728394},{"id":"https://openalex.org/keywords/egfr-signaling","display_name":"EGFR signaling","score":0.7319999933242798},{"id":"https://openalex.org/keywords/vegf-receptors","display_name":"VEGF receptors","score":0.8270000219345093},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.703000009059906},{"id":"https://openalex.org/keywords/tumor-perfusion","display_name":"tumor perfusion","score":0.5989999771118164},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.5849999785423279},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7080000042915344},{"id":"https://openalex.org/keywords/ht-29-cells","display_name":"HT-29 cells","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C2780333294","wikidata":"https://www.wikidata.org/wiki/Q7914515","display_name":"Vandetanib","level":4,"score":0.9725116491317749},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.7026033997535706},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6369293332099915},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6277005076408386},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5527370572090149},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5480974316596985},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5302371978759766},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.4749372601509094},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4035990238189697},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38115793466567993},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3781096637248993},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36715084314346313},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.3507186472415924},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2880004644393921},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-07-1094","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1094","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-1094","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:17975157","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17975157","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unicampania.it:11591/193306","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11591/193306","pdf_url":null,"source":{"id":"https://openalex.org/S7407055255","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi della Campania \"Luigi Vanvitelli\"","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1734613393","display_name":"Development of Mechanism-Based Anticancer Therapy","funder_award_id":"K24CA106349","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G30620217","display_name":"Dual Compartmental Targeting of Cancer","funder_award_id":"R01CA101988","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000891461","display_name":"University of Colorado Cancer Center Support Grant","funder_award_id":"P30CA046934","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1485875137","https://openalex.org/W1507842220","https://openalex.org/W1943596480","https://openalex.org/W1970346999","https://openalex.org/W2000292756","https://openalex.org/W2002049222","https://openalex.org/W2008119533","https://openalex.org/W2009218512","https://openalex.org/W2010300658","https://openalex.org/W2035808363","https://openalex.org/W2043179867","https://openalex.org/W2060479298","https://openalex.org/W2062607891","https://openalex.org/W2069305509","https://openalex.org/W2076184799","https://openalex.org/W2077366285","https://openalex.org/W2087624447","https://openalex.org/W2090699402","https://openalex.org/W2096893939","https://openalex.org/W2099462532","https://openalex.org/W2104311705","https://openalex.org/W2105763574","https://openalex.org/W2110835998","https://openalex.org/W2113060812","https://openalex.org/W2116864064","https://openalex.org/W2118559000","https://openalex.org/W2125916043","https://openalex.org/W2127101185","https://openalex.org/W2133390154","https://openalex.org/W2135900203","https://openalex.org/W2138604360","https://openalex.org/W2140847299","https://openalex.org/W2142564546","https://openalex.org/W2145854263","https://openalex.org/W2152099731","https://openalex.org/W2157769714","https://openalex.org/W2157868564","https://openalex.org/W2165162004","https://openalex.org/W4236891330"],"related_works":["https://openalex.org/W7095340114","https://openalex.org/W2072334819","https://openalex.org/W2517800231","https://openalex.org/W2111870457","https://openalex.org/W2135081135","https://openalex.org/W1251167902","https://openalex.org/W2150310748","https://openalex.org/W2008128911","https://openalex.org/W2085053752","https://openalex.org/W2260420942"],"abstract_inverted_index":{"PURPOSE:":[0],"This":[1],"in":[2,30,34,132,147,155,205,215,232,237,241],"vivo":[3],"study":[4],"was":[5,77,86,130],"designed":[6],"to":[7,120,211],"determine":[8],"the":[9,83,133,136,168,190,206,249],"optimal":[10,238],"doses":[11,53],"and":[12,57,101,170,231,244],"schedules":[13,71,153],"of":[14,39,54,123,139,183,193,199,226,251],"vandetanib,":[15],"a":[16,35],"dual":[17],"epidermal":[18],"growth":[19,24],"factor":[20,25,173],"receptor":[21,26],"(EGFR)-vascular":[22],"endothelial":[23],"tyrosine":[27],"kinase":[28],"inhibitor,":[29],"combination":[31,148,233],"with":[32,51,60,116,149,161,234,255],"irinotecan":[33,63,204],"murine":[36],"xenograft":[37],"model":[38,243],"human":[40],"colon":[41],"cancer.":[42],"EXPERIMENTAL":[43],"DESIGN:":[44],"HT-29":[45],"tumor-bearing":[46],"nude":[47],"mice":[48],"were":[49,103,111,201],"treated":[50],"two":[52],"vandetanib":[55,140,200,227],"(12.5":[56],"25":[58],"mg/kg/d)":[59],"or":[61,69,146],"without":[62],"(100":[64],"mg/kg)":[65],"using":[66,79,88,105],"either":[67],"sequential":[68],"concurrent":[70,207],"for":[72,114,248],"30":[73,181],"days.":[74],"Tumor":[75],"size":[76],"measured":[78],"standard":[80],"variables,":[81],"whereas":[82],"antiangiogenic":[84],"response":[85],"evaluated":[87,113],"dynamic":[89],"contrast-enhanced":[90],"magnetic":[91],"resonance":[92],"imaging.":[93],"Additionally,":[94],"effects":[95,157],"on":[96,158],"EGFR-dependent":[97],"signal":[98],"transduction":[99],"pathways":[100],"proliferation":[102],"assessed":[104],"immunohistochemistry.":[106],"These":[107,151,219],"pharmacodynamic":[108],"end":[109],"points":[110],"then":[112],"associations":[115],"antitumor":[117,128,239],"efficacy":[118,129,240],"and/or":[119],"plasma/tumor":[121],"concentrations":[122,198,225],"vandetanib.":[124],"RESULTS:":[125],"The":[126],"greatest":[127,191],"observed":[131],"groups":[134,188],"receiving":[135],"highest":[137],"dose":[138],"given":[141],"continuously":[142],"(concurrent":[143],"schedule),":[144],"alone":[145,230],"irinotecan.":[150],"dosing":[152],"resulted":[154],"significant":[156],"tumor":[159,197,213],"vasculature,":[160],"decreased":[162,212],"volume":[163],"transfer":[164],"constants,":[165],"area":[166],"under":[167],"curve,":[169],"permeability":[171],"surface":[172],"as":[174,176],"well":[175],"increased":[177,202],"gadolinium":[178],"clearance":[179],"after":[180],"days":[182],"treatment.":[184],"In":[185],"addition,":[186],"these":[187],"showed":[189],"inhibition":[192],"EGFR":[194],"signaling.":[195],"Interestingly,":[196],"by":[203],"schedule,":[208],"possibly":[209],"due":[210],"perfusion":[214],"this":[216,242,256],"group.":[217],"CONCLUSIONS:":[218],"data":[220],"suggest":[221],"that":[222],"higher,":[223],"sustained":[224],"(versus":[228],"intermittent),":[229],"irinotecan,":[235],"result":[236],"may":[245],"have":[246],"implications":[247],"design":[250],"future":[252],"clinical":[253],"studies":[254],"drug.":[257]},"counts_by_year":[{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}